XML 41 R4.htm IDEA: XBRL DOCUMENT v3.19.3
Condensed consolidated statements of operations and comprehensive loss - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Revenue (Note 8)       $ 25,000
Operating expenses        
Research and development (Note 7) $ 1,420 $ 10,713 $ (471) 39,217
Acquired in-process research and development (Note 3) 47,716   47,716  
General and administrative (Note 7) 10,380 4,484 15,358 13,107
Total operating expenses 59,516 15,197 62,603 52,324
Loss from operations (59,516) (15,197) (62,603) (27,324)
Other income, net (Note 9) 384 204 1,262 626
Net loss $ (59,132) $ (14,993) $ (61,341) $ (26,698)
Net loss per common stock – basic and diluted (Note 10) $ (2.26) $ (0.64) $ (2.51) $ (1.14)
Basic and diluted weighted average number of common stock outstanding 26,185,839 23,537,368 24,429,893 23,513,489
Comprehensive loss:        
Net loss $ (59,132) $ (14,993) $ (61,341) $ (26,698)
Other comprehensive income – unrealized gain on available-for-sale securities   2   70
Comprehensive loss $ (59,132) $ (14,991) $ (61,341) $ (26,628)